Entrepreneurship Videos

1. How Tome Biosciences' Rahul Kakkar Balances Medical Practice, Biotech Leadership, and Venture Capital Advising 5/22/2024

   Rahul Kakkar explains his transition from architecture student to MD and how he maintains a cardiology practice while leading Tome Biosciences, which he co-founded.

2. Fed Funding: Creative Capital Generation With James Thomas Coates, Ph.D. 8/1/2022

   As biotech capital markets continue to restrict access to funding for emerging biopharmas, you might be surprised by how many federal dollars get left on the negotiating table. To that end, James Thomas Coates, Ph.D. and his team at Decisive Point have carved out a niche in the venture capital space.

3. Episode 5: Finding Funding In Volatile Times With Ben Zeskind 8/13/2020

   Ben Zeskind launched his biotech, Immuneering, in the throes of the Great Recession. The company earned a $20 million series A round to fund the development of its pipeline at the outset of the COVID-19 pandemic. Along the way, it bootstrapped its way from bioinformatics company to fledgling biopharma. On this episode of The Business Of Biotech, Zeskind shares his experience-based wisdom on finding funding in volatile times.

4. Episode 3: The Biopharma Exit Strategy With Dr. Francois Nader 8/13/2020

   Every new, emerging biopharma company shares a common goal: creating value for its employees, its board, its investors, and ultimately, patients. Along the way, that value creating might get a boost from an IPO, a merger, an acquisition, or steady growth as a private entity. On this episode of The Business Of Biotech, we talk with Dr. Francois Nader—a man who's orchestrated several wildly successful biotech exits—about why it's imperative to begin with the end in mind, and how to navigate your options when the time is right.